Donna L. Dyess

General Surgery
1601 Center St
Mobile, AL 36604

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

The Genomic and Biologic Landscapes of Breast Cancer and Racial Differences.

The Genomic and Biologic Landscapes of Breast Cancer and Racial Differences.

Journal: International journal of molecular sciences
Published: November 04, 2024

Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.

Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.

Journal: NEJM evidence
Published: February 06, 2024

Primary Malignant Peripheral Nerve Sheath Tumor of the Breast: A Rare Case Report and Review of Literature.

Primary Malignant Peripheral Nerve Sheath Tumor of the Breast: A Rare Case Report and Review of Literature.

Journal: Cureus
Published: November 14, 2022

Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.

Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.

Journal: JAMA surgery
Published: May 11, 2022

Resistin: An inflammatory cytokine with multi-faceted roles in cancer.

Resistin: An inflammatory cytokine with multi-faceted roles in cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer
Published: July 08, 2020

Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Journal: Annals of translational medicine
Published: December 07, 2019

Patient and Tumor Disparities in Breast Cancer Based on Insurance Status.

Patient and Tumor Disparities in Breast Cancer Based on Insurance Status.

Journal: The American surgeon
Published: August 21, 2017

Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.

Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.

Journal: Cancer letters
Published: February 14, 2017

Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.

Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.

Journal: Carcinogenesis
Published: November 01, 2016

A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.

A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.

Journal: Clinical breast cancer
Published: October 28, 2016

A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.

A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.

Journal: Oncotarget
Published: August 19, 2016

Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.

Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.

Journal: Oncotarget
Published: January 28, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026